Abstract
Autism spectrum disorder (ASD) is a common and complex neurodevelopmental condition. The pathophysiology of ASD is poorly defined; however, it includes a strong genetic component and there is increasing evidence to support a role of immune dysregulation. Nonetheless, it is unclear which immune phenotypes link to ASD through genetics. Hence, we investigated the genetic correlation between ASD and diverse classes of immune conditions and markers; and if these immune-related genetic factors link to specific autistic- like traits in the population.
We estimated global and local genetic correlations between ASD (n=55,420) and 11 immune phenotypes (n=14,256–755,406) using genome-wide association study summary statistics. Subsequently, polygenic scores (PGS) for these immune phenotypes were calculated in a population-based sample (n=2,487) and associated to five autistic-like traits (i.e., attention to detail, childhood behaviour, imagination, rigidity, social skills), and a total autistic-like traits score. Sex-stratified PGS analyses were also performed.
At the genome-wide level, ASD was positively correlated with allergic diseases (ALG), and negatively correlated with lymphocyte count, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) (FDR-p=0.01-0.02). At the local genetic level, ASD was correlated with RA, C-reactive protein, and granulocytes and lymphocyte counts (p=5.8x10-6–0.002). In the general population sample, increased genetic liability for SLE, RA, ALG, and lymphocyte levels, captured by PGS, was associated with the total autistic score and with rigidity and childhood behaviour (FDR-p=0.03).
In conclusion, we demonstrated a genetic relationship between ASD and immunity that depends on the type of immune phenotype considered; some increase likelihood whereas others may potentially help build resilience. Also, this relationship may be restricted to specific genetic loci and link to specific autistic dimensions (e.g., rigidity).
Highlights
Autism spectrum disorder (ASD) and diseases and traits linked to the immune system share genetic variability
Positive genetic correlation is observed between ASD and atopic diseases
Negative genetic correlation is observed between ASD and autoimmune diseases
Shared genetic loci between ASD and immune-related phenotypes influence gene expression in immune-related tissues and in the developing brain
Immunogenetic factors associate with rigidity and childhood behaviour in the population
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115300 for the project EU-AIMS and no. 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Union Horizon 2020 research and innovation program, the European Federation of Pharmaceutical Industries and Associates, Autism Speaks, Autistica, and SFARI. This paper represents independent research part funded by the NIHR Maudsley Biomedical Research Centre at South London Maudsley NHS Foundation Trust and King s College London. This project has received funding from the European Union Horizon 2020 research and innovation program under grant agreement No. 847879 (PRIME: Prevention and Remediation of Insulin Multimorbidity in Europe). This publication is part of the project No labels needed: understanding psychiatric disorders based on genetic traits (with project number 09150161910091) of the research program Veni which is partly financed by the Dutch Research Council (NWO) Health Research and Development (ZonMW). The analyses were carried out on the Dutch national e-infrastructure, and it is part of the research program Computing Time National Computing Facilities Processing Round pilots 2018 with project No. 17666 which is (partly) financed by the Dutch Research Council (NWO).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board at the Radboud University Medical Center gave ethical approval for this work (CMO 2001/055)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
https://pgc.unc.edu/for-the-public/information-on-disorders/autism-spectrum-disorder/
